Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midazolam as Adjuvant in Quadratus Lumborum Block for C-Section
NCT05261672Unknown
- Sponsor
- Assiut University
- Start
- Mar 2022
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of midazolam in postoperative pain (2 arms), sponsored by Assiut University. Primary endpoint: Rescue analgesia at 24 hours. Status: unknown.
02
Drugs
midazolam
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05261672.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05261672.